Twelve-month natural history of dark adaptation in patients with AMD

Optometry and Vision Science

Volumn 91, Issue 8, 2014, Pages 925-931

  Jackson, Gregory R ^a   Clark, Mark E ^b   Scott, Ingrid U ^a   Walter, Laura E ^a   Quillen, David A ^a   Brigell, Mitchell G ^c  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

Age related macular degeneration; Clinical trial endpoint; Dark adaptation; Human; Longitudinal

Indexed keywords

EXPERIMENTS; MEDICAL APPLICATIONS;

AGE-RELATED MACULAR DEGENERATION; CLINICAL TRIAL; DARK ADAPTATION; HUMAN; LONGITUDINAL;

OPHTHALMOLOGY;

AGED; ARTICLE; BIOASSAY; DARK ADAPTATION; DISEASE COURSE; FEMALE; HUMAN; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PERCEPTIVE THRESHOLD; PHYSIOLOGY; RETINA; RETINA MACULA DEGENERATION; VERY ELDERLY; VISUAL ACUITY; VISUAL DISORDER;

AGED; AGED, 80 AND OVER; DARK ADAPTATION; DISEASE PROGRESSION; ENDPOINT DETERMINATION; FEMALE; HUMANS; MACULAR DEGENERATION; MALE; MIDDLE AGED; RETINA; SENSORY THRESHOLDS; VISION DISORDERS; VISUAL ACUITY;

EID: 84905080905     PISSN: 10405488     EISSN: 15389235     Source Type: Journal    
DOI: 10.1097/OPX.0000000000000247     Document Type: Article

References (25)

1. Curcio CA, Owsley C, Jackson GR. Spare the rods, save the cones in aging and age-related maculopathy. Invest Ophthalmol Vis Sci 2000; 41: 2015-8.
2. Lamb TD, Pugh EN, Jr. Dark adaptation and the retinoid cycle of vision. Prog Retin Eye Res 2004; 23: 307-80.
3. Brown B, Tobin C, Roche N, Wolanowski A. Cone adaptation in age-related maculopathy. Am J Optom Physiol Opt 1986; 63: 450-4.
4. Brown B, Adams AJ, Coletta NJ, Haegerstrom-Portnoy G. Dark adaptation in age-related maculopathy. Ophthalmic Physiol Opt 1986; 6: 81-4.
5. Midena E, Degli Angeli C, Blarzino MC, Valenti M, Segato T. Macular function impairment in eyes with early age-related macular degeneration. Invest Ophthalmol Vis Sci 1997; 38: 469-77.
6. Steinmetz RL, Haimovici R, Jubb C, Fitzke FW, Bird AC. Symptomatic abnormalities of dark adaptation in patients with age-related Bruch's membrane change. Br J Ophthalmol 1993; 77: 549-54.
7. Owsley C, Jackson GR, White M, Feist R, Edwards D. Delays in rodmediated dark adaptation in early age-related maculopathy. Ophthalmology 2001; 108: 1196-202.
8. Owsley C, McGwin G, JacksonGR, Heimburger DC, Piyathilake CJ, Klein R, White MF, Kallies K. Effect of short-term, high-dose retinol on dark adaptation in aging and early age-related maculopathy. Invest Ophthalmol Vis Sci 2006; 47: 1310-8.
9. Owsley C, McGwin G, Jr., Jackson GR, Kallies K, Clark M. Coneand rod-mediated dark adaptation impairment in age-related maculopathy. Ophthalmology 2007; 114: 1728-35.
10. Dimitrov PN, Guymer RH, Zele AJ, Anderson AJ, Vingrys AJ. Measuring rod and cone dynamics in age-related maculopathy. Invest Ophthalmol Vis Sci 2008; 49: 55-65.
11. Jackson GR, Edwards JG. A short-duration dark adaptation protocol for assessment of age-related maculopathy. J Ocul Biol Dis Infor 2008; 1: 7-11.
12. ClarkME, McGwin G, Jr., Neely D, Feist R, Mason JO, 3rd, Thomley M, White MF, Jr., Ozaydin B, Girkin CA, Owsley C. Association between retinal thickness measured by spectral-domain optical coherence tomography (OCT) and rod-mediated dark adaptation in non-exudative age-related maculopathy. Br J Ophthalmol 2011; 95: 1427-32.
13. Eisner A, Stoumbos VD, Klein ML, Fleming SA. Relations between fundus appearance and function. Eyes whose fellow eye has exudative age-related macular degeneration. Invest Ophthalmol Vis Sci 1991; 32: 8-20.
14. Dimitrov PN, Robman LD, Varsamidis M, Aung KZ, Makeyeva GA, Guymer RH, Vingrys AJ. Visual function tests as potential biomarkers in age-related macular degeneration. Invest Ophthalmol Vis Sci 2011; 52: 9457-69.
15. Dimitrov PN, Robman LD, Varsamidis M, Aung KZ, Makeyeva G, Busija L, Vingrys AJ, Guymer RH. Relationship between clinical macular changes and retinal function in age-related macular degeneration. Invest Ophthalmol Vis Sci 2012; 53: 5213-20.
16. Haimovici R, Owens SL, Fitzke FW, Bird AC. Dark adaptation in age-related macular degeneration: relationship to the fellow eye. Graefes Arch Clin Exp Ophthalmol 2002; 240: 90-5.
17. Davis MD, Gangnon RE, Lee LY, Hubbard LD, Klein BE, Klein R, Ferris FL, Bressler SB, Milton RC. The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17. Arch Ophthalmol 2005; 123: 1484-98.
18. Beck RW, Moke PS, Turpin AH, Ferris FL, 3rd, SanGiovanni JP, Johnson CA, Birch EE, Chandler DL, Cox TA, Blair RC, Kraker RT. A computerized method of visual acuity testing: adaptation of the early treatment of diabetic retinopathy study testing protocol. Am J Ophthalmol 2003; 135: 194-205.
19. Owsley C, Jackson GR, Cideciyan AV, Huang Y, Fine SL, Ho AC, MaguireMG, Lolley V, Jacobson SG. Psychophysical evidence for rod vulnerability in age-related macular degeneration. Invest Ophthalmol Vis Sci 2000; 41: 267-73.
20. Curcio CA. Photoreceptor topography in ageing and age-related maculopathy. Eye (Lond) 2001; 15: 376-83.
21. Siderov J, Tiu AL. Variability of measurements of visual acuity in a large eye clinic. Acta Ophthalmol Scand 1999; 77: 673-6.
22. Bland JM, Altman DG. Measurement error. BMJ 1996; 312: 1654.
23. Holfort SK, Jackson GR, Larsen M. Dark adaptation during transient hyperglycemia in type 2 diabetes. Exp Eye Res 2010; 91: 710-4.
24. Holfort SK, Norgaard K, Jackson GR, Hommel E, Madsbad S, Munch IC, Klemp K, Sander B, Larsen M. Retinal function in relation to improved glycaemic control in type 1 diabetes. Diabetologia 2011; 54: 1853-61.
25. Owsley C, McGwin G, Jr., Scilley K, Kallies K. Development of a questionnaire to assess vision problems under low luminance in agerelated maculopathy. Invest Ophthalmol Vis Sci 2006; 47: 528-35.